The market of Adderall B974 – a scheduled drug at 30mg – presents significant challenges within Oz. While not officially registered for distribution by the Therapeutic Goods Administration, anecdotal evidence suggest its importation via grey channels. This limited availability fuels fears regarding security, potential diversion, and the lack of